Background. Wound infections caused by Staphylococcus aureus are associated with significant morbidity and mortality. The staphylococcal extracellular adherence protein (Eap) has been shown to delay wound healing by interfering with host defense and angiogenesis, yet the expression of Eap in the human wound is required to exert these functions.
Staphylococcus aureus is responsible for a variety of diseases, ranging from superinfected skin pustules to such life-threatening conditions as osteomyelitis, endocarditis, and sepsis [1] . For wound and nosocomial infections, it is one of the most frequently isolated pathogens [2, 3] , and it is the most common pathogen among diabetic and venous leg ulcers [2, 4] . Infections are established by a wide spectrum of virulence factors that enable S. aureus to invade the target tissue and maintain the infection [5] . Adherence of staphylococci to target tissues is an important first step, one that can be accomplished by membrane-bound as well as secreted adhesion factors [6] .
Within the group of secreted expanded-repertoire adhesive molecules (SERAMs), the extracellular adherence protein (Eap) of S. aureus is of particular interest and has been the target of several recent studies [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] . To establish a successful infection, bacteria have to accomplish several steps, such as invasion of the host, adherence to and persistence in tissue, and escape from the immune system. Eap enhances the adhesion of staphylococci to the target tissue by binding to a variety of extracellular matrix components, such as vitronectin, fibrinogen, fibronectin, and collagens [14, [17] [18] [19] . It confers adhesion to and internalization into endothelial cells [18 -21] . Eap blocks the interaction between intracellular adhesion molecule 1 and the ␤ 2 -integrin receptor and, therefore, diminishes leukocyte adhesion to en-dothelial cells in vitro [16, 22] . It reduces neutrophil recruitment [23] as well as T cell proliferation and responses [16, 24] . Our group recently showed that Eap abrogates the mitogenic and sprouting response by endothelial cells and diminishes the production of tissue factor and decay accelerating factor [15] . Bacterial populations colonizing chronic wounds typically exist as highly persistent biofilm, which contributes to delayed wound healing as well as to reduced susceptibility to antimicrobial treatment [25, 26] ; most recently, Eap has also been attributed a role in the production of biofilm [10] . In concert, these properties provide Eap with numerous prerequisites required for establishing a chronic infection.
Although many studies have addressed various functions of Eap in vitro, little is known about its role in vivo. Experiments using animal models have revealed a profound delay in wound healing as well as diminished neutrophil immigration in a model of peritonitis [13] . Comparison between wild-type S. aureus and an isogenic ⌬eap mutant showed markedly decreased abscess formation for the mutant when examined after several weeks [24] . However, it is still not clear whether Eap is of relevance in authentic human infection. Although we have shown previously that the encoding gene, eap, is present in all strains of S. aureus analyzed to date [9] , the availability of expression data on this gene is limited and has been obtained from in vitro studies only. Bacteria possess the ability to specifically adapt to a changing host environment, leading to differences in transcription and protein expression in vitro and in vivo. This has been shown for other target genes in animal models [27] [28] [29] [30] [31] [32] [33] . Therefore, the aim of the present study was to determine the in vivo and in vitro transcription levels of eap in clinical isolates, so as to provide a rationale for a role for Eap in authentic wound infection.
METHODS

Acquisition of patient material for in vivo studies.
A total of 21 patients presenting with infected chronic wounds and delayed wound healing were included in the present study. In accordance with Food and Drug Administration guidelines, chronic wounds were defined as those that had failed to proceed through an orderly and timely series of events to produce durable, structural, functional, and cosmetic closure [34] . The duration of each wound was at least 4 weeks. Superficial wounds were limited to the epidermis/dermis, whereas deep wounds affected underlying structures, such as deep soft tissue, fascia, muscle, or bone. After local ethics committee approval was received, informed consent was obtained from all participating patients. Swab samples were collected from patients with wounds that were known to be or suspected to be infected with S. aureus. For in vivo transcription analysis, a cotton swab was immersed in 400 L of PBS and applied to the most suspicious part of the wound. The swab was then swiveled in PBS thoroughly and discarded, and the suspension was snap-frozen in liquid nitrogen directly at bedside. A second swab (Transwab for Aerobes and Anaerobes; Medical Wire and Equipment) was subjected to routine bacteriological analysis. S. aureus was identified by its distinct morphological characteristics, hemolysis, and agglutination (Pastorex Staph Plus Kit; Bio-Rad).
Bacterial strains and growth conditions. Wound isolates and blood culture isolates (table 1) were grown in brain-heart infusion (BHI) broth at 150 rpm and 37°C in Erlenmayer flasks, with a culture-to-flask volume of 1:3 and a starting inoculum of 1:100. S. aureus blood culture isolates from patients with bacteremia/sepsis were taken from our diagnostic laboratory. The Newman strain, which produces a high level of Eap, was included as positive control. Bacterial growth was monitored by measuring the optical density at 600 nm (OD 600 ).
RNA isolation from frozen human samples. Samples were thawed on ice in the presence of 900 L of TRI Reagent solution (Ambion; Applied Biosystems), and RNA was isolated as described by the manufacturer, using zirconia-silica beads (Lysing Matrix B; MP Biomedicals) and a Ribolyser instrument (Fast- Prep FP120; MP Biomedicals) for 20 s. For elimination of contaminating DNA, RNA samples were incubated with 10 U of RNAse-free DNAse I (Roche) for 30 min at 37°C, aliquoted, and directly stored at Ϫ70°C. The absence of contaminating DNA was proven for each sample by real-time polymerase chain reaction (PCR), using gyrB-specific primers (table 2) . RNA isolation from culture. Bacteria were grown for 2 or 8 h, and 1 mL of culture was pelleted and lysed in 1 mL of TRI Reagent solution. RNA isolation was performed as described above.
Quantification of specific transcripts by real-time PCR. Specific sequence-modified RNA standards for the quantification of eap and gyrB (as a housekeeping gene) mRNA were prepared as described elsewhere [31] . In brief, we designed gene-specific primers with a 5' extension that included the T7 promoter sequence for eap as well for gyrB (table 1) . T7-driven in vitro transcription was generated using a standard transcription assay (T7 MEGAShortscript; Ambion). After subsequent DNase I (Roche Biomedicals) treatment, RNA was recovered using the MEGAclear Kit (Ambion), and RNA quantification was performed spectrophotometrically.
Reverse transcription. RNA was transcribed using the High-Capacity cDNA Archive Kit (Applied Biosystems), in accordance with the manufacturer's instructions. For each transcription, 2.5 L of total RNA solution was used. cDNAs were aliquoted and directly frozen.
Real-time PCR. cDNA solution (2.5 L) was used for realtime PCR, which was performed on the instrument from the ABI Prism 7000 Sequence Detection System in combination with the SYBR Green Master Mix Kit from Applied Biosystems. Master mixes were prepared in accordance with the manufacturer's instructions. Primers were designed using the Primer Express software (version 2.0.0; Applied Biosystems) (table 2). Specific RNA standards for the quantification of gyrB and eap mRNA were run simultaneously with each probe, and samples and standards were run in duplicate. All results were expressed as copies of eap per copy of gyrB. Sequence-specific standard curves were obtained using 10-fold serial dilutions (1 ϫ 10 9 -1 ϫ 10 2 copies/ mL) of the respective RNA standard. The number of copies for each sample was calculated using the ABI Prism 7000 Sequence Detection System software. spa typing. All isolates were characterized by spa typing [35] . spa types were designated using the StaphType software (Ridom) and were clustered into clonal complexes (spa-CCs) using the BURP (based upon repeat pattern) algorithm, with the calculated cost between members of a group 8 and the exclusion of spa types shorter than 5 repeats (table 1) .
SDS extraction of cell wall-associated proteins. Bacteria were grown in BHI broth, and samples were taken after 2 and 8 h. All samples were normalized to an OD 600 of 6.0. After centrifugation at 6000 g for 5 min at 4°C, cell-surface proteins were selectively extracted by resuspension in extraction buffer (2% SDS in 125 mmol/L Tris-HCl [pH 7.0]) and incubated at 95°C for 3 min in a shaker. Cell fractions were eliminated by centrifugation at 10,000 g for 3 min at 4°C. Supernatants were subsequently analyzed by SDS-PAGE, followed by Western blot analysis using an anti-Eap monoclonal antibody (F3H10; provided by J. Patti, Inhibitex).
Statistical analysis. For statistical analysis, the Wilcoxon signed-rank test and the Mann-Whitney rank-sum test were used. P Ͻ .05 was considered to indicate statistical significance. (table 1) . Three strains shorter than 5 repeats were excluded, and 5 strains were found without alignment. Most of the spa-CCs and singletons could be detected in both strain collections, indicating that no particular S. aureus strains are associated with wound infections. Set-up and validation of quantitative real-time PCR for the detection of eap and gyrB transcripts. Several primer pairs for the amplification of eap have been published, mostly as part of studies investigating S. aureus Newman [9, 36, 37] . However, a sequence alignment of eap from all S. aureus genomes published to date revealed a significant polymorphism in this gene, and sequence analysis of eap from 6 of our blood culture isolates confirmed the strong heterogeneity within this gene (data not shown). This heterogeneity made it impossible to use established primers or to design a primer pair that would meet the specific requirements for a quantitative real-time PCR. Indeed, using a single primer pair, we initially observed amplification of eap transcripts for all strains but with varying primer efficiencies in the real-time PCR, thus rendering it unsuitable for a quantitative analysis. Accordingly, we had to combine 3 primers-2 differing forward primers and 1 reverse primer (table 2)-to ensure that all known gene variants were included. To confirm the universal character of this primer mix, we used 6 genomic eap PCR fragments derived from our blood culture isolates as templates for the real-time PCR with the aforementioned primer mix. Identical efficiencies of the PCR were obtained for all templates.
RESULTS
Distribution of different
Transcription of eap by blood culture isolates under in vitro conditions. After establishment and validation of the quantitative real-time PCR, we studied the in vitro transcription of 50 S. aureus isolates derived from positive blood cultures. All isolates displayed similar growth curves that were comparable to that of the laboratory strain Newman, a high-level eap producer [18, 37] (data not shown). Analysis of eap transcription by the Newman strain during growth in BHI broth revealed that eap transcription increased along with growth, being highest after 8 h of incubation (data not shown), in line with previous reports showing higher eap transcription or expression in the stationary phase than in the exponential phase [18, 38, 39] . We therefore chose to examine eap transcription after 2 (exponential phase) and 8 (stationary phase) h of growth. We found that all blood culture isolates produced eap, although transcription varied largely among these isolates ( figure 1A ). In line with previous findings [18, 37] , the Newman strain displayed the highest eap transcription. For all strains, transcription was significantly higher during the stationary phase than during the exponential phase (P Ͻ .001, Wilcoxon signed-rank test) ( figure 1A ). Grouping the isolates as a function of their susceptibility toward methicillin revealed no significant difference (figure 1B). Furthermore, no correlation could be found between transcription levels and spa types, and grouping the blood culture isolates as function of clinical presentation (catheter-associated bacteremia vs. bacteremia caused by deep-seated infections) yielded no significant difference (data not shown). Transcription of eap by isolates from human wound infections. For examination of authentic eap transcription in infected chronic wounds, we collected wound-swab samples from 22 patients presenting with clinical wound entities ranging from mild and superficial infected skin lesions to severe deepsoft-tissue infections. In parallel, a second swab was obtained for S. aureus culture. For a few patients, Ͼ1 S. aureus isolate could be recovered. In addition to the in vivo samples, all isolates were grown in vitro and subjected to eap expression analysis. Figure 2 shows the distribution of eap transcription for all isolates for 2 h, 8 h, and in vivo. All isolates transcribed eap in vitro, and in general eap transcript levels during the stationary phase exceeded those of the exponential phase. Furthermore, in vivo transcription of eap was detectable for all isolates, displaying a higher variability than that seen in vitro. Overall, transcription was found to be significantly higher in vivo than in vitro (for in vivo vs. 2 h, P ϭ .007; for in vivo vs. 8 h, P Ͻ .001; Wilcoxon signed-rank test) (figure 2). In fact, for all isolates (21 of 21) a higher transcription of eap was detected in vivo than during the exponential phase, and for most isolates (17 of 21) superior transcription levels were observed in vivo than during the stationary phase, with some isolates showing an elevation of up to 100-fold. The majority of isolates even displayed higher eap transcription in vivo relative to the respective in vitro (2 h) transcription of the high-expressing laboratory strain Newman (figure 2).
Transcription analysis according to wound type. Grouping all clinical isolates by wound type revealed significant differences in eap transcription in vivo-isolates obtained from deep-wound infections yielded higher levels of eap transcripts than did isolates obtained from superficial skin infections (P Ͻ .01, Mann-Whitney rank-sum test) ( figure 3 ). No such difference between these 2 groups was observed under in vitro conditions.
Comparison of eap transcription patterns according to isolate origin. To determine whether the origin of the S. aureus isolates might affect eap transcription, we compared the in vitro eap transcript levels of the wound isolates with those of the blood culture isolates. Although no clear difference in eap transcription between these 2 groups was detected for the exponential phase, we found a significant difference (P Ͻ .001, by MannWhitney rank-sum test) for the stationary phase, with S. aureus that caused bacteremia or sepsis producing more eap than wound isolates ( figure 4) .
Correlation between transcription and expression of Eap. To confirm that changes in transcription actually lead to changes in the production of Eap, we analyzed the expression of Eap by S. aureus strain Newman and by 2 clinical isolates, one obtained from a superficial wound (isolate 21) and another obtained from a deep soft-tissue infection (isolate 30), during both the exponential and stationary phases ( figure 5A ). In line with our transcriptional data, the amount of Eap increased along with culture time, with the Newman strain producing considerable larger quantities of Eap (note that only 1:10 of sample was applied to the gel for the Newman strain). For comparison, figure 5B shows the transcription levels for both clinical isolates as well as for the Newman strain. The size of Eap among strains of S. aureus varies between 40 and 72 kDa (including the Newman strain) depending on the underlying sequence [37, 40] , which explains the difference in size for isolate 30 depicted in figure 5A . Other clinical isolates displayed similar levels of Eap expression (data not shown).
DISCUSSION
In the present study, we report that eap is transcribed in all tested isolates obtained from authentic wound infections. Furthermore, in vivo eap transcription results obtained for wound specimens showed a significant elevation in comparison to the in vitro transcription results for cultured isolates. Although eap is apparently prevalent in all S. aureus strains [9] , an earlier report found that only 14 of 20 examined PCR-positive strains actually expressed Eap in vitro [37] . Thus, to our knowledge, this is the first time that profound differences in this important virulence determinant have been observed when analyses were performed with bacterial mRNA directly recovered from in situ human infection relative to mRNA extracted from isolates grown in vitro.
To date, only a limited number of studies addressing the transcription of staphylococcal virulence determinants in vivo have been conducted, and these studies have almost exclusively described results from experimental infection models [27] [28] [29] [31] [32] [33] . It is noteworthy that most of these studies have reported substantial differences in virulence factor production in vitro and in vivo, indicating that regulatory circuits other than those found in vitro might be pivotal in vivo. For instance, the activation of the central global regulator agr and the expression of its effector molecule, RNAIII, greatly differs between each experimental condition: although in vitro agr is activated during the late exponential and stationary phases, in experimental infection, agr is inactive through extended infection periods, resulting in reduced expression of agr-dependent toxins, such as ␣-toxin [28] . In fact, in vivo agr may undergo even more com- plex activation patterns, given that it has been shown to be activated in an eclipse-type manner with very late activation [33] . Similarly, another global regulator, sae, also demonstrates significant differences in expression in vitro versus in vivo in animal models [31, 41] .
Although experimental infections are clearly of interest for analysis of in vivo gene expression compared with that in humans, fundamental differences in rodent anatomy and physiology exist, and defense mechanisms vary greatly between humans and other animals [42, 43] . In fact, in rodents, induction of local immunosuppression (such as the presence of a foreign body) is necessary to generate persistent S. aureus infection [44, 45] . Although these reports underline the importance of experimental infection models, the impact of virulence gene expression in humans is undoubtedly more appropriately investigated directly in patients. Therefore, we established an assay that allowed us to monitor the transcription of eap in authentic human wound infection.
In addition to the fact that eap is unequivocally expressed in vivo, eap transcription was found to be significantly higher in deep wounds than in superficial wounds. In vitro, on the other hand, no marked variation in transcription between these 2 wound types was observed, again indicating that interaction between bacteria and the host (rather than strain characteristics) is operational. In chronic wounds, the difference between colonization and invasive infection is clinically not always unambiguous. One reason for the observed differences in eap transcription might be that superficial wounds are colonized rather than infected, which might lead to the activation of differing regulatory circuits. Blood culture isolates displayed significantly higher eap transcription in vitro, compared with wound isolates. Pathophysiologically, it is unclear whether this is a cause or consequence of the endovascular passage, which might select adhering, invading, and immunomodulating Eap-expressing isolates. Obtaining a definite answer by analyzing transcription levels in vivo in blood is challenging; at present, it is not possible with our assay.
Although either one or a combination of the above-outlined assumptions may contribute to the differences in eap expression in vivo, it is unlikely that methodological aspects (such as different amplification efficiencies) may account for these observed differences. Despite the diversity of the eap nucleotide sequences in published S. aureus genomes, we obtained identical efficiencies on primer optimization, indicating that the straindependent variation in eap transcription obtained by real-time PCR was not the result of differences in PCR efficiency.
Under in vitro conditions, the global regulatory locus sae controls transcription of eap [36] , yet little is known about sae activation in vivo. Interestingly, we have obtained preliminary data on the transcription of sae (which itself is positively regulated by its effector molecule, SaeR [46] ) that indicated that, in clinical wound isolates, an elevated transcription of sae is found in vivo (C.W., unpublished data). This suggests that the sae-eap axis is also functional in vivo.
These analyses do not yet prove that the expressed protein, Eap, is of importance for the initiation and/or persistence of S. aureus in infected wounds. However, in light of the large number of reports ascribing pathophysiological functions relevant for the pathogenesis of wound infections to Eap, our results now prove unequivocally that transcription of eap is elevated in S. aureus-infected wounds. These observations add an important rationale to link the pathophysiological functions of Eap (such as interference with antiangiogenesis and immunomodulation) with authentic clinical disease.
The present results, although statistically significant, were obtained in a relatively small cohort of patients from one center. Transcription analysis in vivo is challenging: access to patients with proven or suspected infection with S. aureus has to be ascertained before the initiation of therapy, because high bacterial loads are a prerequisite for successful mRNA isolation. However, by establishing and optimizing the methods, proof of principle for direct transcription analyses of infected patients' specimens has been achieved. On this basis, additional investigations that include larger patient cohorts and/or additional factors considered to be important for S. aureus infection (such as other SERAMs or MSCRAMMs [microbial surface components recognizing adhesive matrix molecules]) are warranted.
